EMA Issues Positive CHMP Opinions for Biocon’s Denosumab Biosimilars
Commercialization of Ustekinumab and Golimumab Biosimilars
Bio-Thera Solutions Expands Partnership with SteinCares to Market Two Biosimilars in LATAM
Celltrion Launches STEQEYMA (ustekinumab) in Germany and the Netherlands
PTAB Institutes Sarepta’s IPR
Biogen’s TOFIDENCE (tocilizumab) Approved in the EU
USPTO Proposed Rulemaking Regarding Terminal Disclaimers
Genentech and Dr. Reddy’s Settle BPCIA Rituximab Litigation
Celltrion Submits BLA for Omalizumab Biosimilar
Subscribe: Subscribe via RSS
Blogs
Firm/Org